Tags

Type your tag names separated by a space and hit enter

Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
J Sex Med. 2008 Aug; 5(8):1955-64.JS

Abstract

INTRODUCTION

The Sexual Experience Questionnaire (SEX-Q) enables quick and easy assessment of functional, emotional, and satisfaction-related aspects of the sexual experience in men with erectile dysfunction (ED).

AIM

To assess correlations between improvement on the SEX-Q and outcomes on other validated questionnaires. METHODS. Men with ED (score < or =25 on the Erectile Function domain of the International Index of Erectile Function [IIEF]) who had used less than or equal to six doses of any phosphodiesterase 5 inhibitor (none within 6 months) were randomized to 10 weeks of double-blind, placebo-controlled (DBPC) flexible-dose sildenafil citrate (50 or 100 mg, as needed), followed by 6 weeks of open-label (OL) sildenafil.

MAIN OUTCOME MEASURES

SEX-Q, IIEF, Quality of Erection Questionnaire (QEQ), Self-Esteem and Relationship (SEAR) Questionnaire, Erection Hardness Score (EHS), successful intercourse attempts (SIAs), Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), and global efficacy questions (GEQs).

RESULTS

Compared with the placebo group (N = 105), the sildenafil group (N = 104) at DBPC end of treatment (EOT) had significantly more improvement (P < 0.05) on all SEX-Q, IIEF (except the Sexual Desire domain), QEQ, and SEAR outcomes, more frequent SIAs and EHS 3 (hard enough for penetration but not completely hard) or EHS 4 (completely hard) erections (odds ratio [OR], 2.52 and 3.46, respectively), EHS 4 erections four times as often (OR, 6.41), more men satisfied with treatment (EDITS; OR, 2.6), approximately twice as many men with improved erections (GEQ1; OR, 5.8) and ability to have sexual intercourse (GEQ2; OR, 5.4), and GEQ3 scores that indicated better sex (P < 0.0001). SEX-Q score improvements correlated positively with all other outcomes. At OL EOT, most outcomes were >60% (and approximately half were > or =80%) of the maximum positive result.

CONCLUSIONS

SEX-Q change scores correlate with several other functional, emotional, and satisfaction-related outcomes in men treated with sildenafil for ED, allowing a simple and focused evaluation of the sexual experience.

Authors+Show Affiliations

Urology San Antonio Research, PA, San Antonio, TX 78229, USA. Leroy.jones@urologysa.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18564150

Citation

Jones, LeRoy A., et al. "Effect of Sildenafil Citrate On the Male Sexual Experience Assessed With the Sexual Experience Questionnaire: a Multicenter, Double-blind, Placebo-controlled Trial With Open-label Extension." The Journal of Sexual Medicine, vol. 5, no. 8, 2008, pp. 1955-64.
Jones LA, Klimberg IW, McMurray JG, et al. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. J Sex Med. 2008;5(8):1955-64.
Jones, L. A., Klimberg, I. W., McMurray, J. G., Padula, R., Tseng, L. J., & Stecher, V. J. (2008). Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. The Journal of Sexual Medicine, 5(8), 1955-64. https://doi.org/10.1111/j.1743-6109.2008.00879.x
Jones LA, et al. Effect of Sildenafil Citrate On the Male Sexual Experience Assessed With the Sexual Experience Questionnaire: a Multicenter, Double-blind, Placebo-controlled Trial With Open-label Extension. J Sex Med. 2008;5(8):1955-64. PubMed PMID: 18564150.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. AU - Jones,LeRoy A, AU - Klimberg,Ira W, AU - McMurray,James G, AU - Padula,Rebecca, AU - Tseng,Li-Jung, AU - Stecher,Vera J, Y1 - 2008/06/28/ PY - 2008/6/20/pubmed PY - 2008/12/25/medline PY - 2008/6/20/entrez SP - 1955 EP - 64 JF - The journal of sexual medicine JO - J Sex Med VL - 5 IS - 8 N2 - INTRODUCTION: The Sexual Experience Questionnaire (SEX-Q) enables quick and easy assessment of functional, emotional, and satisfaction-related aspects of the sexual experience in men with erectile dysfunction (ED). AIM: To assess correlations between improvement on the SEX-Q and outcomes on other validated questionnaires. METHODS. Men with ED (score < or =25 on the Erectile Function domain of the International Index of Erectile Function [IIEF]) who had used less than or equal to six doses of any phosphodiesterase 5 inhibitor (none within 6 months) were randomized to 10 weeks of double-blind, placebo-controlled (DBPC) flexible-dose sildenafil citrate (50 or 100 mg, as needed), followed by 6 weeks of open-label (OL) sildenafil. MAIN OUTCOME MEASURES: SEX-Q, IIEF, Quality of Erection Questionnaire (QEQ), Self-Esteem and Relationship (SEAR) Questionnaire, Erection Hardness Score (EHS), successful intercourse attempts (SIAs), Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), and global efficacy questions (GEQs). RESULTS: Compared with the placebo group (N = 105), the sildenafil group (N = 104) at DBPC end of treatment (EOT) had significantly more improvement (P < 0.05) on all SEX-Q, IIEF (except the Sexual Desire domain), QEQ, and SEAR outcomes, more frequent SIAs and EHS 3 (hard enough for penetration but not completely hard) or EHS 4 (completely hard) erections (odds ratio [OR], 2.52 and 3.46, respectively), EHS 4 erections four times as often (OR, 6.41), more men satisfied with treatment (EDITS; OR, 2.6), approximately twice as many men with improved erections (GEQ1; OR, 5.8) and ability to have sexual intercourse (GEQ2; OR, 5.4), and GEQ3 scores that indicated better sex (P < 0.0001). SEX-Q score improvements correlated positively with all other outcomes. At OL EOT, most outcomes were >60% (and approximately half were > or =80%) of the maximum positive result. CONCLUSIONS: SEX-Q change scores correlate with several other functional, emotional, and satisfaction-related outcomes in men treated with sildenafil for ED, allowing a simple and focused evaluation of the sexual experience. SN - 1743-6109 UR - https://www.unboundmedicine.com/medline/citation/18564150/Effect_of_sildenafil_citrate_on_the_male_sexual_experience_assessed_with_the_Sexual_Experience_Questionnaire:_a_multicenter_double_blind_placebo_controlled_trial_with_open_label_extension_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1743-6095(15)32129-9 DB - PRIME DP - Unbound Medicine ER -